Fengcai Zhu is currently the deputy director of Jiangsu Provincial Center for Disease Control and Prevention, chief physician, doctoral supervisor, the first-level training target of Jiangsu Province’s “333 Project”, and selected into the “National Hundred Thousand Talents Project”. He has successively won the honorary titles of “Young and Middle-aged Experts with Outstanding Contributions” and “National Outstanding Science and Technology Workers” from the Ministry of Personnel, the National Health and Family Planning Commission, and Jiangsu Province. He is mainly engaged in infectious disease prevention and control research. As the main researcher, he is responsible for more than 100 vaccine clinical evaluations, including the only five innovative vaccines in his country in recent years, and has contributed to his country’s transition from a major vaccine user to a major R&D power; he led the team to confirm the world’s first human infection with H7N4 avian influenza. He screened and prepared a variety of fully human monoclonal antibodies against a variety of viruses, inventing more than 10 related patents. He has presided over five provincial and ministerial-level projects, including major scientific and technological projects, “863” projects, and the National Natural Science Foundation; won nine provincial and ministerial-level scientific and technological awards; published more than 400 papers, more than 100 of which were included in SCI.
Hui Jin obtained his B.S. in Preventive Medicine in 1998, Master in Epidemiology and Health Statistics in 2003 and PhD in Environment Epidemiology in 2011 from Southeast University of China, respectively. He is now a professor at the Department of Epidemiology and Health Statistics in Southeast University. From 1998 to 2001 he worked in Huludao Worker’s Hospital as a pediatrician. He joined the School of Public Health, Southeast University in 2003. In 2013, he worked as a residential fellow at the Hopkins-Nanjing Center for Chinese and American Studies, Nanjing, China. He has been engaged in the research and development of infectious disease epidemiology for more than 15 years. His current research interests include health technology assessment in complex systems, such as the evaluation of vaccines, diagnosis and treatment methods, and the development of hierarchical medical systems. As a vice-dean, he also focused on the reform and development of global public health education, for example, he had been engaged in the comparative study between U.S. and Chinese public health education systems. He has published more than 20 SCI papers in Lancet, Transfusion, Vaccine, Plosone, Epidemiol Infect, Hum Vacc Immunother and other well-known scientific journals. His papers were ever awarded as the most influential excellent academic papers in China in 2009 and 2012. He was associate editor of Hum Vacc Immunother and editor of other well-known scientific journals.
